febit to Introduce Geniom RT Analyzer® to U.S. Market at RNAi World Congress
Complete the form below to unlock access to ALL audio articles.
febit holding gmbh has announced it will introduce the Geniom RT Analyzer® to the U.S. market at RNAi World Congress, which will take place April 30-May 2 in Boston.
According to Company, RNA-researchers, one of the main user groups of its new device, will benefit from the microarray technology device's high degree of automation and flexibility. In addition, microRNA researchers will enjoy its recently released microarray based on Sanger miRBase-Version 11.0.
The latest product in febit's Geniom family, the Geniom RT Analyzer is designed to enable the fully automated processing of microarrays on febit's own Geniom biochips. The compact all-in-one device, which employs microfluidics, can provide users with high sample throughput, reproducibility and a variety of applications. In addition, the product's freely programmable and temperature control optimizes hybridizations and can enable the use of enzymatic reactions directly on the microfluidic array for signal enhancement and primer extension assays.
